Cara Therapeutics (CARA)
$16.34
0.05 (0.31%)
CARA Stock Quote Delayed 15 Minutes
Previous Close
$16.34
Market Cap
553.51M
PE Ratio
-10.47
EPS
-1.56
Volume (Avg. Vol.)
990,700
Day's Range
15.73 - 16.52
52-Week Range
14.10 - 27.55
Dividend & Yield
N/A (N/A)
CARA Stock Predictions, Articles, and Cara Therapeutics News
Why This Just Might Be the Biggest Week for CARA Stock
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
Even with a Pharma Arm, Canopy Growth Stock Is About Recreational Use
It's not a great reason in and of itself to buy CGC stock , but Canopy Growth does have an overlooked presence in the medical cannabis arena.
With Trial Results Due, This Could Be a Breakout Year for Cara Stock
Putting in the work may pay off big for In 2018, setting up the clinical studies dominated Cara Therapeutics' activities. For 2019, the study results may drive Cara stock higher. stock
Cara Therapeutics Stock Could Outperform in 2019
CARA stock could be meaningfully boosted by drug development updates in 2019
The Trade War Could Be a Positive Catalyst for Cara Therapeutics Stock
Growing pressure to take action against China's illicit drug production could make investors more interested in CARA stock, potentially causing Cara Therapeutics stock to rally.
Why Cara Therapeutics Stock Is Soaring Today
Cara Therapeutics (CARA) shares were up more than 11% on Wednesday as the company received good news regarding its latest clinical trial.
3 Stocks to Watch on Wednesday: Square Inc (SQ), Cara Therapeutics Inc (CARA) and Healthcare Services Group, Inc. (HCSG)
Square (SQ) continues its breathtaking 2017 rally Wednesday, Cara Therapeutics (CARA) jumps on trial results and Healthcare Services Group (HCSG) scores a post-earnings bump.
Why Best Buy Co Inc (BBY), Abercrombie & Fitch Co. (ANF) and Cara Therapeutics Inc (CARA) Are 3 of Today’s Worst Stocks
Too bad for Cara Therapeutics (CARA), Abercrombie & Fitch (ANF) and Best Buy (BBY) owners -- the market doesn't do do-overs.
Why Pandora Media Inc (P), Cara Therapeutics Inc (CARA) and Micron Technology, Inc. (MU) Are 3 of Today’s Worst Stocks
Micron Technology (MU), Pandora (P) and Cara Therapeutics (CARA) all ended the trading week on a bearish foot, but for understandable reasons.
Why Cara Therapeutics Inc (CARA) Stock Is Plunging Today
Cara Therapeutics (CARA) stock was hit hard on Friday following poor results in its Phase 2b trial of osteoarthritis oral drug CR845.
Marijuana Stocks: Cara Therapeutics Inc (CARA) Stock Soars on FDA Breakthrough Therapy Status
Cara Therapeutics (CARA) stock was flying high on Friday following good news from the U.S. Food and Drug Administration.
Why Sears Holdings Corp (SHLD), Cara Therapeutics Inc (CARA) and Exxon Mobil Corporation (XOM) Are 3 of Today’s Worst Stocks
Cara Therapeutics (CARA), Sears Holdings (SHLD) and Exxon Mobil (XOM) and the day and the week on a low note, though for understandable reasons.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
